New App Helps Predict Pediatric Transplant Need Representing the rare liver disease community at Alpha-1 Foundation 2024 conference We are honored to have had the opportunity to...
Global Liver Institute
Indications of Advancements and a Promising Outlook – Liver Cancer News
Spotlighting Disparities in Pediatric Liver Cancer Treatment A study published in the Journal of Pediatrics by Dr. David Hills-Dunlap revealed that sociodemographic factors significantly influence...
Global Liver Institute Supports U.S. House Ways and Means Committee’s Markup of Legislation to Expand Obesity Care Coverage
Global Liver Institute Supports the U.S. House Ways and Means Committee's Markup of Legislation to Expand Obesity Care CoverageGlobal Liver Institute strongly supports the amendment to be considered...
Policy, Prevention, and Progress: Fatty Liver & Obesity
Policy, Prevention, and Progress: Fatty Liver & Obesity Dr. Kelly Brownell, Dean Emeritus of the Sanford School of Public Policy at Duke University, has over 35 years of experience studying food...
Perils of AI in Healthcare
Perils of AI in Healthcare Donna Cryer, JD and Deborah SobelAs the founder and CEO of Global Liver Institute (GLI), and a liver transplant patient myself, I know it is imperative to connect the dots...
From Awareness to Action on Global Fatty Liver Day
From Awareness to Action on Global Fatty Liver Day Global Liver Institute Unites the Field in Times of Name Changes and New Treatments(Washington, DC - June 13, 2024) – Today marks the seventh...
GLI Celebrates with PBC Patient Community upon U.S. FDA’s Approval of Second-Line Treatment
GLI Celebrates with PBC Patient Community upon U.S. FDA’s Approval of Second-Line Treatment(Washington, D.C. June 10, 2024) – Global Liver Institute (GLI) celebrates the decision of the U.S. Food...
Access to care takes center stage for liver disease patients – Liver Health Policy Update
GLI responds to VA efforts to deny or delay access to NASH/MASH treatment while proactively pushing for Congress to advance policies that support access to comprehensive care for liver disease...
The Quiet Threat of Fatty Liver in Lean Individuals
The Quiet Threat of Fatty Liver in Lean Individuals Nonalcoholic fatty liver disease (NAFLD or more recently metabolic dysfunction-associated steatotic liver disease, MASLD) has long been associated...
Nourishing Insights into Pediatric Fatty Liver Disease
Nourishing Insights into Pediatric Fatty Liver DiseaseOver the past decade, the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD, previously known as nonalcoholic fatty...
Recent News